The invention relates to the technical field of bacteria resisting gels, and particularly relates to a bacteria resistance and inhibiting private care gel for resisting gynecological diseases. The gelcomprises, by weight, 86.0-90.0% of water, 0.3-0.5% of carbomer-940, 3.0-5.0% of glycerol, 3.0-5.0% of butanediol, 0.1-0.2% of allantoin, 0.1-0.2% of methyl hydroxybenzoate, 0.5-1.5% of colloidal silver, 0.05-0.15% of chlorhexidine gluconate, 0.05-0.15% of chlorhexidine acetate, 0.02-0.15% of borneol, 0.2-3% of radix sophorae flavescentis extracts, 0.2-3% of fructus cnidii extracts, 0.05-3.0% ofchitosan, 0.3-0.5% of triethanolamine, 0.02-0.2% of fullerene, 1.5-2.5% of polyquaternium, 0.1-0.2% of 1,2-hexanediol, 0.09-0.2% of phenoxetol, 0.03-0.1% of ethylhexyl glycerin, 0.1-0.3% of PEG-40 hydrogenated castor oil and 0.01-0.05% of mentholum. According to the gel, by adding various kinds of effective ingredients of the radix sophorae flavescentis extracts, the fructus cnidii extracts, the colloidal silver, the chlorhexidine gluconate, the chlorhexidine acetate, the fullerene and the like,the care gel has strong bacteria resistance on staphylococcus aureus, bacillus coli and candida albicans, there exists no irritation on vaginal mucosa, and there exists no irritation reaction on skin.